JP2022548869A5 - - Google Patents
Info
- Publication number
- JP2022548869A5 JP2022548869A5 JP2022516358A JP2022516358A JP2022548869A5 JP 2022548869 A5 JP2022548869 A5 JP 2022548869A5 JP 2022516358 A JP2022516358 A JP 2022516358A JP 2022516358 A JP2022516358 A JP 2022516358A JP 2022548869 A5 JP2022548869 A5 JP 2022548869A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201921036803 | 2019-09-12 | ||
| IN201921036803 | 2019-09-12 | ||
| PCT/IB2020/058464 WO2021048809A1 (en) | 2019-09-12 | 2020-09-11 | Novel substituted sulfoximine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022548869A JP2022548869A (ja) | 2022-11-22 |
| JP2022548869A5 true JP2022548869A5 (https=) | 2023-08-01 |
| JPWO2021048809A5 JPWO2021048809A5 (https=) | 2023-08-01 |
Family
ID=74866664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022516358A Pending JP2022548869A (ja) | 2019-09-12 | 2020-09-11 | 新規な置換スルホキシミン誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12377070B2 (https=) |
| EP (1) | EP4027986A4 (https=) |
| JP (1) | JP2022548869A (https=) |
| CN (1) | CN114746087A (https=) |
| WO (1) | WO2021048809A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024180521A1 (en) * | 2023-03-02 | 2024-09-06 | Zydus Lifesciences Limited | Treatment for inflammatory bowel disease |
| WO2025153532A1 (en) | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4666506A (en) * | 1984-08-08 | 1987-05-19 | E. I. Du Pont De Nemours And Company | Herbicidal pyrimidines |
| US5258406A (en) | 1991-12-20 | 1993-11-02 | Eli Lilly And Company | Sulfonimidamides |
| PT1270565E (pt) * | 1997-01-29 | 2004-09-30 | Pfizer | Furano-2-sulfonamida 4-substituida e sua utilizacao na preparacao de derivados de sulfonilureia |
| US6906063B2 (en) * | 2000-02-04 | 2005-06-14 | Portola Pharmaceuticals, Inc. | Platelet ADP receptor inhibitors |
| SI3259253T1 (sl) | 2015-02-16 | 2020-07-31 | The University Of Queensland | Sulfonilsečnine in sorodne spojine ter njihova uporaba |
| WO2018225018A1 (en) * | 2017-06-09 | 2018-12-13 | Cadila Healthcare Limited | Novel substituted sulfoximine compounds |
| EP3668840A1 (en) * | 2017-08-15 | 2020-06-24 | Inflazome Limited | Novel sulfonamide carboxamide compounds |
| WO2019043610A1 (en) * | 2017-08-31 | 2019-03-07 | Cadila Healthcare Limited | NEW SUBSTITUTED SULFONYLUREA DERIVATIVES |
| EP3692020A1 (en) * | 2017-10-03 | 2020-08-12 | Inflazome Limited | Novel compounds |
| EA202191968A1 (ru) * | 2019-01-14 | 2021-11-16 | Кадила Хелзкэр Лимитед | Новые замещенные производные сульфонилмочевины |
| EP4110058A4 (en) * | 2020-02-28 | 2024-03-20 | Zydus Lifesciences Limited | Novel substituted sulfonylurea and sulfoximineurea derivatives |
-
2020
- 2020-09-11 US US17/642,184 patent/US12377070B2/en active Active
- 2020-09-11 CN CN202080078065.1A patent/CN114746087A/zh active Pending
- 2020-09-11 EP EP20862312.4A patent/EP4027986A4/en active Pending
- 2020-09-11 JP JP2022516358A patent/JP2022548869A/ja active Pending
- 2020-09-11 WO PCT/IB2020/058464 patent/WO2021048809A1/en not_active Ceased